Email Updates

Search form

You are here

AVAC in the News

  • AVAC Program Manager Angelo Kaggwa-Katumba is named among Uganda’s Top 40 men under 40 in a special edition of Sunday Vision, a publication of the Ugandan media giant New Vision. The Top 40 singles out 40 men and 40 women under the age of 40 for their leadership as role models for the next generation of Ugandans. Kaggwa-Katumba’s work advocating for rights-based HIV prevention and helping to strengthen partnerships across civil society in Africa was applauded by the publishers.

    November 27, 2016
    New Vision
  • During the US election campaign, plenty was said about emails and sexual harassment. But there was little or no talk on global health or HIV. That has left Mitchell Warren, the head of AVAC, worried.

    November 25, 2016
  • We are writing in response to a commentary by Dr Ronald Goldman titled, “Recommendation of circumcision for HIV prevention is biased” that appeared in the 2 November 2016 edition of The Namibian...Dr Goldman's commentary has many unsubstantiated and incorrect claims and we want to address some of them here and why we believe VMMC is an important part of Namibia's response to HIV.

    November 23, 2016
    The Namibian
  • Researchers and advocates must ensure it is not perceived as exclusively a treatment for marginalized groups, which will lower its appeal both within those communities but also to other people who could benefit from it.

    November 18, 2016
  • Gilead is not following the accepted standard for community engagement in its new pre-exposure prophylaxis (PrEP) trial, and we are among a coalition of HIV activists and organizations from Europe and North America calling them out on their bad corporate behavior. We root our criticism in the Good Participatory Practice (GPP) guidelines that were inspired, in part, by controversies in earlier PrEP trials.

    November 16, 2016
    The Body
  • US president-elect Donald Trump is likely to be as indifferent to Africa as he was when he made his first foreign policy campaign speech in April—when he barely mentioned the continent.

    November 10, 2016
    Times LIve
  • Infusions of an antibody against HIV were safe and appeared to suppress the virus briefly when anti-retroviral medications were stopped, researchers said. But in two small phase I clinical trials, HIV rebounded within weeks of stopping standard triple-drug therapy.

    November 9, 2016
    Antibody Related Research
    MedPage Today
  • A new report has revealed how research and development for AIDS vaccines, microbicides, pre-exposure prophylaxis using antiretroviral drugs (PrEP) and treatment as prevention (TasP) are in danger of being slowed or even sidelined because of inadequate funding.

    October 26, 2016
    The Herald
  • An aggressive program of voluntary male circumcision in Kenya—a procedure shown to reduce the risk of acquiring HIV—has already prevented thousands of infections, a researcher said here.

    October 20, 2016
    MedPage Today
  • The need for PrEP to be used in conjunction with condoms was highlighted when scientists announced that a second man taking the daily HIV-prevention pill had contracted a rare, drug-resistant strain of the virus.

    October 20, 2016